{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T04:27:10Z","timestamp":1792902430894,"version":"4.5.0"},"reference-count":45,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:00:00Z","timestamp":1616112000000},"content-version":"unspecified","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","award":["ZIA-DC00008"],"award-info":[{"award-number":["ZIA-DC00008"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2021,2,24]]},"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>As heterogeneous tumors develop in the face of intact immunity, tumor cells harboring genomic or expression defects that favor evasion from T-cell detection or elimination are selected. For patients with such tumors, T cell-based immunotherapy alone infrequently results in durable tumor control.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Here, we developed experimental models to study mechanisms of T-cell escape and demonstrated that resistance to T-cell killing can be overcome by the addition of natural killer (NK) cells engineered to express a chimeric antigen receptor (CAR) targeting programmed death ligand-1 (PD-L1).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In engineered models of tumor heterogeneity, PD-L1 CAR-engineered NK cells (PD-L1 t-haNKs) prevented the clonal selection of T cell-resistant tumor cells observed with T-cell treatment alone in multiple models. Treatment of heterogenous cancer cell populations with T cells resulted in interferon gamma (IFN-\u03b3) release and subsequent upregulation of PD-L1 on tumor cells that escaped T-cell killing through defects in antigen processing and presentation, priming escape cell populations for PD-L1 dependent killing by PD-L1 t-haNKs in vitro and in vivo.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These results describe the underlying mechanisms governing synergistic antitumor activity between T cell-based immunotherapy that results in IFN-\u03b3 production, upregulation of PD-L1 on T-cell escape cells, and the use of PD-L1 CAR-engineered NK cells to target and eliminate resistant tumor cell populations.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jitc-2020-002128","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T12:17:35Z","timestamp":1616156255000},"page":"e002128","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":41,"title":["Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells"],"prefix":"10.1136","volume":"9","clinical-trial-number":[{"clinical-trial-number":"nct03429036","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02858310","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03429036","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7226-4855","authenticated-orcid":false,"given":"Maxwell Y","family":"Lee","sequence":"first","affiliation":[{"name":"NIDCD, National Institutes of Health, Bethesda, Maryland, USA"},{"name":"Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"Robbins","sequence":"additional","affiliation":[{"name":"NIDCD, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Sievers","sequence":"additional","affiliation":[{"name":"NIDCD, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Friedman","sequence":"additional","affiliation":[{"name":"NIDCD, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1975-3726","authenticated-orcid":false,"given":"Houssein","family":"Abdul Sater","sequence":"additional","affiliation":[{"name":"Genitourinary Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E","family":"Clavijo","sequence":"additional","affiliation":[{"name":"NIDCD, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Judd","sequence":"additional","affiliation":[{"name":"Mid-Atlantic Permanente Medical Group, Rockville, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Tsong","sequence":"additional","affiliation":[{"name":"Mid-Atlantic Permanente Medical Group, Rockville, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Silvin","sequence":"additional","affiliation":[{"name":"NIDCD, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Soon-Shiong","sequence":"additional","affiliation":[{"name":"NantKwest, Culver City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle R","family":"Padget","sequence":"additional","affiliation":[{"name":"Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7932-4072","authenticated-orcid":false,"given":"Jeffrey","family":"Schlom","sequence":"additional","affiliation":[{"name":"Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Hodge","sequence":"additional","affiliation":[{"name":"Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hinrichs","sequence":"additional","affiliation":[{"name":"Genitourinary Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6586-5804","authenticated-orcid":false,"given":"Clint","family":"Allen","sequence":"additional","affiliation":[{"name":"NIDCD, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,3,19]]},"reference":[{"key":"2025100307571668000_9.3.e002128.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32591-7"},{"key":"2025100307571668000_9.3.e002128.2","doi-asserted-by":"publisher","DOI":"10.1038\/nature22991"},{"key":"2025100307571668000_9.3.e002128.3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/jamaoncol.2018.4051","article-title":"Combining immune checkpoint blockade and tumor-specific vaccine for patients with incurable human papillomavirus 16-related cancer: a phase 2 clinical trial","volume":"5","author":"Massarelli","year":"2019","journal-title":"JAMA Oncol"},{"key":"2025100307571668000_9.3.e002128.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1609279"},{"key":"2025100307571668000_9.3.e002128.5","doi-asserted-by":"publisher","DOI":"10.1126\/science.1251102"},{"key":"2025100307571668000_9.3.e002128.6","doi-asserted-by":"publisher","DOI":"10.1126\/science.1203486"},{"key":"2025100307571668000_9.3.e002128.7","doi-asserted-by":"publisher","DOI":"10.1038\/nature10755"},{"key":"2025100307571668000_9.3.e002128.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1604958"},{"key":"2025100307571668000_9.3.e002128.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.12.033"},{"key":"2025100307571668000_9.3.e002128.10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.02424"},{"key":"2025100307571668000_9.3.e002128.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1113205"},{"key":"2025100307571668000_9.3.e002128.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.10.044"},{"key":"2025100307571668000_9.3.e002128.13","doi-asserted-by":"publisher","DOI":"10.1038\/ni1582"},{"key":"2025100307571668000_9.3.e002128.14","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13411"},{"key":"2025100307571668000_9.3.e002128.15","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000450"},{"key":"2025100307571668000_9.3.e002128.16","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.54854","article-title":"Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells","volume":"9","author":"Robbins","year":"2020","journal-title":"Elife"},{"key":"2025100307571668000_9.3.e002128.17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s43018-020-0036-4","article-title":"Schumacher TNM: Long-distance modulation of bystander tumor cells by CD8(+) T cell-secreted IFNgamma","volume":"1","author":"Hoekstra","year":"2020","journal-title":"Nat Cancer"},{"key":"2025100307571668000_9.3.e002128.18","unstructured":"Team RC . R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2019 URL. https:\/\/wwwR-projectorg\/"},{"key":"2025100307571668000_9.3.e002128.19","unstructured":"Kolde R . pheatmap: pretty Heatmaps. R package version 1.0.12, 2019. Available: https:\/\/CRANR-projectorg\/package=pheatmap"},{"key":"2025100307571668000_9.3.e002128.20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5"},{"key":"2025100307571668000_9.3.e002128.21","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99488","article-title":"Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model","volume":"3","author":"Jin","year":"2018","journal-title":"JCI Insight"},{"key":"2025100307571668000_9.3.e002128.22","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2750"},{"key":"2025100307571668000_9.3.e002128.23","doi-asserted-by":"publisher","DOI":"10.1385\/IR:33:2:113"},{"key":"2025100307571668000_9.3.e002128.24","doi-asserted-by":"publisher","DOI":"10.1038\/nature23270"},{"key":"2025100307571668000_9.3.e002128.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.08.069"},{"key":"2025100307571668000_9.3.e002128.26","doi-asserted-by":"publisher","DOI":"10.1038\/nature14129"},{"key":"2025100307571668000_9.3.e002128.27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI80005"},{"key":"2025100307571668000_9.3.e002128.28","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.14"},{"key":"2025100307571668000_9.3.e002128.29","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.22.012703.104803"},{"key":"2025100307571668000_9.3.e002128.30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00262-002-0332-0","article-title":"Analysis of HLA expression in human tumor tissues","volume":"52","author":"Cabrera","year":"2003","journal-title":"Cancer Immunol Immunother"},{"key":"2025100307571668000_9.3.e002128.31","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2008.273"},{"key":"2025100307571668000_9.3.e002128.32","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2229-5"},{"key":"2025100307571668000_9.3.e002128.33","doi-asserted-by":"publisher","DOI":"10.1038\/nature23477"},{"key":"2025100307571668000_9.3.e002128.34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01062-w"},{"key":"2025100307571668000_9.3.e002128.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.10.001"},{"key":"2025100307571668000_9.3.e002128.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.11.006"},{"key":"2025100307571668000_9.3.e002128.37","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-1860"},{"key":"2025100307571668000_9.3.e002128.38","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118958"},{"key":"2025100307571668000_9.3.e002128.39","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.1.335"},{"key":"2025100307571668000_9.3.e002128.40","doi-asserted-by":"publisher","DOI":"10.1038\/ni860"},{"key":"2025100307571668000_9.3.e002128.41","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s43018-020-0038-2","article-title":"Bystander IFN-\u03b3 activity promotes widespread and sustained cytokine signaling altering the tumor microenvironment","volume":"1","author":"Thibaut","year":"2020","journal-title":"Nat Cancer"},{"key":"2025100307571668000_9.3.e002128.42","doi-asserted-by":"publisher","DOI":"10.1172\/JCI91190"},{"key":"2025100307571668000_9.3.e002128.43","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar6711"},{"key":"2025100307571668000_9.3.e002128.44","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000246"},{"key":"2025100307571668000_9.3.e002128.45","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.4_suppl.TPS463","article-title":"NANT cancer vaccine an orchestration of immunogenic cell death by overcoming immune suppression and activating NK and T cell therapy in patients with third line or greater metastatic pancreatic cancer","volume":"37","author":"Seery","year":"2019","journal-title":"JCO"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2020-002128","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T14:57:24Z","timestamp":1759503444000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2020-002128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,19]]},"published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1136\/jitc-2020-002128"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2020-002128","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}